ARTIVION, INC.·4

Nov 18, 1:03 PM ET

Davis John E 4

4 · ARTIVION, INC. · Filed Nov 18, 2025

Insider Transaction Report

Form 4
Period: 2025-11-14
Davis John E
Chief Commercial Officer
Transactions
  • Exercise/Conversion

    Stock Options (Right to buy)

    2025-11-146,3930 total
    Exercise: $29.62From: 2020-03-05Exp: 2026-03-05Common Stock (6,393 underlying)
  • Sale

    Common Stock

    2025-11-14$44.67/sh6,393$285,575198,842 total
  • Exercise/Conversion

    Common Stock

    2025-11-17$29.62/sh+6,394$189,390205,236 total
  • Exercise/Conversion

    Stock Options (Right to buy)

    2025-11-176,3940 total
    Exercise: $29.62From: 2020-03-05Exp: 2026-03-05Common Stock (6,394 underlying)
  • Exercise/Conversion

    Common Stock

    2025-11-14$29.62/sh+6,393$189,361205,235 total
  • Sale

    Common Stock

    2025-11-17$45.17/sh6,394$288,817198,842 total
Footnotes (2)
  • [F1]The option exercise and subsequent sale reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2025.
  • [F2]Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was March 5, 2020.

Documents

1 file
  • 4
    wk-form4_1763488988.xmlPrimary

    FORM 4